For healthcare professionals only



BMJ 1996; 312 doi: (Published 20 April 1996) Cite this as: BMJ 1996;312:992

Long term adjuvant therapy for primary breast cancer

An error occurred in this editorial by R D Bulbrook (17 February, pp 389-90). In the sixth paragraph, the third sentence should read, “…the American trial of the use of tamoxifen for the prevention of breast cancer [not: both the Scottish and the American trails in primary breast cancer] contains so large a proportion of young women that they are [not: it is] unlikely to have sufficient power to provide significant data on the effects of tamoxifen on cardiovascular disease.”

View Abstract